Close

Analyst Ratings for Array BioPharma (ARRY)

ARRY Rating Summary

  |   Expand Research on ARRY
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/8/2011 BMO Capital N/A New Coverage Market Perform
(N/A)
3.00
(N/A)
2.21
(2.07)
-6.33% Details
7/23/2010 UBS N/A Upgrade Buy
(N/A)
N/A
(N/A)
3.09
(2.07)
-33.01% Details